Abstract:BACKGROUND:Copy number variations (CNVs) of chromosomal region 22q11.2 are associated with a subset of patients with congenital heart disease (CHD). Accurate and efficient detection of CNV is important for genetic analysis of CHD. The aim of the study was to introduce a novel approach named CNVplex®, a high-throughput analysis technique designed for efficient detection of chromosomal CNVs, and to explore the prevalence of sub-chromosomal imbalances in 22q11.2 loci in patients with CHD from a single institute.RESULTS:We developed a novel technique, CNVplex®, for high-throughput detection of sub-chromosomal copy number aberrations. Modified from the multiplex ligation-dependent probe amplification (MLPA) method, it introduced a lengthening ligation system and four universal primer sets, which simplified the synthesis of probes and significantly improved the flexibility of the experiment. We used 110 samples, which were extensively characterized with chromosomal microarray analysis and MLPA, to validate the performance of the newly developed method. Furthermore, CNVplex® was used to screen for sub-chromosomal imbalances in 22q11.2 loci in 818 CHD patients consecutively enrolled from Shanghai Children's Medical Center. In the methodology development phase, CNVplex® detected all copy number aberrations that were previously identified with both chromosomal microarray analysis and MLPA, demonstrating 100% sensitivity and specificity. In the validation phase, 22q11.2 deletion and 22q11.2 duplication were detected in 39 and 1 of 818 patients with CHD by CNVplex®, respectively. Our data demonstrated that the frequency of 22q11.2 deletion varied among sub-groups of CHD patients. Notably, 22q11.2 deletion was more commonly observed in cases with conotruncal defect (CTD) than in cases with non-CTD (P<0.001). With higher resolution and more probes against selected chromosomal loci, CNVplex® also identified several individuals with small CNVs and alterations in other chromosomes.CONCLUSIONS:CNVplex® is sensitive and specific in its detection of CNVs, and it is an alternative to MLPA for batch screening of pathogenetic CNVs in known genomic loci.

Copy Number Variation-Associated Lncrnas May Contribute to the Etiologies of Congenital Heart Disease

Identification of Long Non-coding RNA Candidate Disease Genes Associated with Clinically Reported CNVs in Congenital Heart Disease

Integrated analysis of copy number variation-associated lncRNAs identifies candidates contributing to the etiologies of congenital kidney anomalies

Long Noncoding RNA <i>lnc-TSSK2-8</i> Activates Canonical Wnt/-Catenin Signaling Through Small Heat Shock Proteins HSPA6 and CRYAB

Copy Number Variation Analysis in Chinese Children with Complete Atrioventricular Canal and Single Ventricle

Copy Number Variation Ofgata4andnkx2-5In Chinese Fetuses with Congenital Heart Disease

Genome-wide Copy Number Variant Analysis for Congenital Ventricular Septal Defects in Chinese Han Population

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

The implication of chromosomal abnormalities in the surgical outcomes of Chinese pediatric patients with congenital heart disease

Copy Number Variation of GATA4 and NKX2-5 in Chinese Fetuses with Congenital Heart Disease.

Association of copy number variation in X chromosome-linked PNPLA4 with heterotaxy and congenital heart disease

Copy Number Variant Analysis for Syndromic Congenital Heart Disease in the Chinese Population.

De novo and inherited micro-CNV at 16p13.11 in 21 Chinese patients with defective cardiac left-right patterning

The use of high-resolution SNP arrays to detect congenital cardiac defects

EP06.06: Analysis of Copy Number Variations in Fetal Conotruncal Heart Defects Using Low‐coverage Whole Genome Sequencing

[Analysis of Genomic Copy Number Variations in Two Unrelated Neonates with 8p Deletion and Duplication Associated with Congenital Heart Disease].

Exploring The Effect Of Differentially Expressed Long Non-Coding Rnas Driven By Copy Number Variation On Competing Endogenous Rna Network By Mining Lung Adenocarcinoma Data

A Modified Multiplex Ligation-Dependent Probe Amplification Method for the Detection of 22q11.2 Copy Number Variations in Patients with Congenital Heart Disease.

Chromosome Microarray Testing for Patients with Congenital Heart Defects Reveals Novel Disease Causing Loci and High Diagnostic Yield

Rare de novo copy number variants in patients with congenital pulmonary atresia.

Identification of Rare Copy Number Variants Associated with Pulmonary Atresia with Ventricular Septal Defect